Acerus Pharmaceuticals Co. (OTCMKTS:TRLPF – Get Free Report)’s stock price crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.22 and traded as high as $0.22. Acerus Pharmaceuticals shares last traded at $0.22, with a volume of 0 shares traded.
Acerus Pharmaceuticals Stock Performance
The company’s 50-day simple moving average is $0.22 and its 200-day simple moving average is $0.22. The stock has a market capitalization of $56.90 million, a price-to-earnings ratio of -2.75 and a beta of 2.60. The company has a current ratio of 1.35, a quick ratio of 0.90 and a debt-to-equity ratio of 0.64.
About Acerus Pharmaceuticals
Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for men's and women's health. The company offers Natesto, a nasal gel for testosterone replacement therapy in adult males diagnosed with hypogonadism; Estrace, an oral tablet for the symptomatic relief of menopausal symptoms; and UriVarx, a natural health product that helps reduce symptoms of hyperactive bladder, such as daytime urinary frequency, urgency, and nocturia.
Featured Stories
- Five stocks we like better than Acerus Pharmaceuticals
- Most Volatile Stocks, What Investors Need to Know
- Semtech Stock Climbs as AI Boom Drives Turnaround Success
- How to Calculate Inflation Rate
- 3 Companies Leading the Way With Aggressive Stock Buybacks
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Is It Time to Buy Nuclear Energy Stocks After the Latest Dip?
Receive News & Ratings for Acerus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acerus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
